The COVID-19 pandemic has rapidly transformed the clinical trials landscape. What is happening to data as clinical trials become increasingly decentralized? Join Darshan Kulkarni as he talks with guests Craig Lipset, Artem Andrianov and Moe...
There is growing pressure being placed on pharmaceutical companies to make their clinical trials more transparent. Despite this pressure, there remain privacy concerns about publicizing clinical research data. How can companies successfully balance...
23andMe as well as other spit-in-a-tube genetics companies have been profiting off of selling consumers’ genetic data to drugmakers, but recently, 23andMe took a more explicit step when they partnered with drug giant GlaxoSmithKline. 23andMe...